Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023


Werte in diesem Artikel
Aktien

0.22 EUR 0.00 EUR -1.86 %

SUNNYVALE, Calif., July 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 9, 2023.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is (877) 344-7529 (USA) or (412) 317-0088 (international), conference ID: 2309660.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the first quarter of fiscal 2024.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on FacebookLinkedInTwitter, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-fiscal-year-end-2023-financial-results-on-august-9-2023-301884939.html

SOURCE Accuray Incorporated

Aktuelle Accuray Aktie News

Werbung

Accuray Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accuray nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
30.11.17 Accuray Buy Lake Street
22.12.15 Accuray Sector Perform RBC Capital Markets
01.05.15 Accuray Buy Dougherty & Company LLC
12.01.15 Accuray Outperform Northland Capital
06.11.07 Accuray günstig bewertet Global Biotech Investing